Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) EV-to-FCF : 0.00 (As of Jun. 05, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Parnell Pharmaceuticals Holdings's Enterprise Value is $0.00 Mil. Parnell Pharmaceuticals Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2018 was $-3.14 Mil. Therefore, Parnell Pharmaceuticals Holdings's EV-to-FCF for today is 0.00.

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's EV-to-FCF or its related term are showing as below:

PARNF's EV-to-FCF is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 22.555
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Parnell Pharmaceuticals Holdings's stock price is $0.0001. Parnell Pharmaceuticals Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 was $0.007. Therefore, Parnell Pharmaceuticals Holdings's PE Ratio for today is 0.01.

Parnell Pharmaceuticals Holdings EV-to-FCF Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings EV-to-FCF Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

EV-to-FCF

Get a 7-Day Free Trial

-6.08

-3.19

-2.31

-10.04

-10.21

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
EV-to-FCF	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Parnell Pharmaceuticals Holdings's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's EV-to-FCF falls into.

Parnell Pharmaceuticals Holdings EV-to-FCF Calculation

Parnell Pharmaceuticals Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	0.000	/	-3.137
	=	0.00

Parnell Pharmaceuticals Holdings's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Parnell Pharmaceuticals Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2018 was $-3.14 Mil.

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) EV-to-FCF Explanation

Parnell Pharmaceuticals Holdings's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0001	/	0.007
	=	0.01

Parnell Pharmaceuticals Holdings's share price for today is $0.0001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Parnell Pharmaceuticals Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 was $0.007.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Parnell Pharmaceuticals Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » EV-to-FCF

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.